本頁面由Tiger Trade Technology Pte. Ltd.提供服務

The Oncology Institute

2.96
-0.1400-4.52%
盤後2.94-0.0200-0.68%18:49 EDT
成交量:207.23萬
成交額:629.28萬
市值:2.91億
市盈率:-5.44
高:3.16
開:3.10
低:2.94
收:3.10
52周最高:4.88
52周最低:0.9700
股本:9,838.13萬
流通股本:8,243.95萬
量比:1.06
換手率:2.51%
股息:- -
股息率:- -
每股收益(TTM):-0.5445
每股收益(LYR):-0.5445
淨資產收益率:-4132.17%
總資產收益率:-13.37%
市淨率:-18.52
市盈率(LYR):-5.44

資料載入中...

2023/03/09

重要事件披露

8-K - Current report
2023/01/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/01

重要事件披露

8-K - Current report
2022/11/15

重要事件披露

8-K - Current report
2022/11/09

重要事件披露

8-K - Current report
2022/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/23

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/09/22

重要事件披露

8-K - Current report
2022/09/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/08

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/08/16

重要事件披露

8-K - Current report
2022/08/10

重要事件披露

8-K - Current report
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/15

重要事件披露

8-K - Current report
2022/07/12

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/11

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/19

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933